Claire Andréjak (University Hospital Amiens, Amiens, France) shares her expert clinical perspectives on the current challenges for diagnosis and treatment of nontuberculous mycobacteria (NTM) infections and how to optimise patient management moving forward.
Questions1. What are the main challenges encountered in nontuberculous mycobacterium (NTM) diagnosis? (0:12)
2. Why are current NTM guidelines poorly adhered to in clinical practice? (1:25)
3. What is the most effective management plan following NTM diagnosis? (2:16)
4. What are the main limitations of current treatment options for patients with NTM? (3:08)
5. What are the emerging treatment options in NTM infection? (3:46)
Speaker disclosure: Claire Andréjak has nothing to disclose in relation to this video interview.
Filmed at the European Respiratory Society (ERS) International Congress 2018, Paris, France, September 2018, supported by an unrestricted independent educational grant from Insmed.